🛡️ Public data only — no PHI permitted on this instance.

HOSP

NEW YORK EYE AND EAR INFIRMARY

CCN 330100|LOC NEW YORK, NY|BEDS 15|NPR $112.8M|MARGIN -28.0%

SeekingChartis Score

INVESTMENT THESIS

Selective: NEW YORK EYE AND EAR INFIRMARY

/ 100 (C)

+$8.3M

EBITDA Uplift

+736bps

Margin Δ

0.0%

Op Margin

$112.8M

Revenue

—

Realization

—

Peer Rank

SIGNAL STRENGTH

Margin

0.0%

Safety

56%

CATALYSTS

▲RCM uplift of $8.3M (+736bps)

RISKS

▼Elevated distress risk (44%)

▼Small facility — limited scale economies

Hold / Selective — investigate specific opportunities but be prepared for execution risk.

Peer Analysis EBITDA Bridge Data Room IC Memo ML Detail

$112.8M

Net Patient Revenue

-28.0%

Operating Margin

$-31.5M

Net Income

Licensed Beds

$7,523K

Revenue per Bed

$144.4M

Operating Expenses

Payer Mix

PYR

■ MEDICARE · 1%■ MEDICAID · 0%■ COMMERCIAL · 99%

Score Breakdown

SCComposite · 14/100

Component	Score	Max	%
Market Position	11	35	31%
Financial Health	1	25	2%
Operational Quality	0	20	0%
Competitive Moat	0	20	1%

Comparable Hospitals

CMP

CCN	Hospital	Beds	NPR
330004	THE KINGSTON HOSPITAL	147	$0M
330005	KALEIDA HEALTH	954	$0M
330006	ST. JOSEPHS MEDICAL CENTER	106	$0M
330008	WYOMING COUNTY COMMUNITY HOSPITAL	47	$0M
330009	BRONXCARE HEALTH SYSTEM	454	$0M

Team Notes

NOTE0 entries

Actions

ACT

WFDiligence Workflow

Competitive Intel EBITDA Bridge Data Room IC Memo Scenarios

AIDeep Analysis

ML Analysis Demand 3-Year History Stats Bayesian

FINFinancial Models

DCF LBO 3-Statement Returns Market Denial

MORE IN NYStart Diligence · creates a deal from HCRIS